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Abstract
The Mycobacterium tuberculosis complex (MTBC) is a group of related pathogens that
cause tuberculosis (TB) in mammals. MTBC species are distinguished by their ability to sus-
tain in distinct host populations. While Mycobacterium bovis (Mbv) sustains transmission
cycles in cattle and wild animals and causes zoonotic TB, M. tuberculosis (Mtb) affects
human populations and seldom causes disease in cattle. The host and pathogen determi-
nants underlying host tropism between MTBC species are still unknown. Macrophages are
the main host cell that encounters mycobacteria upon initial infection, and we hypothesised
that early interactions between the macrophage and mycobacteria influence species-spe-
cific disease outcome. To identify factors that contribute to host tropism, we analysed blood-
derived primary human and bovine macrophages (hMϕ or bMϕ, respectively) infected with
Mbv and Mtb. We show that Mbv and Mtb reside in different cellular compartments and dif-
ferentially replicate in hMϕ whereas both Mbv and Mtb efficiently replicate in bMϕ. Specifi-
cally, we show that out of the four infection combinations, only the infection of bMϕ with Mbv
promoted the formation of multinucleated giant cells (MNGCs), a hallmark of tuberculous
granulomas. Mechanistically, we demonstrate that both MPB70 from Mbv and extracellular
vesicles released by Mbv-infected bMϕ promote macrophage multinucleation. Importantly,
we extended our in vitro studies to show that granulomas from Mbv-infected but not Mtb-
infected cattle contained higher numbers of MNGCs. Our findings implicate MNGC forma-
tion in the contrasting pathology between Mtb and Mbv for the bovine host and identify
MPB70 from Mbv and extracellular vesicles from bMϕ as mediators of this process.
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Author summary
The identification of host and pathogen factors contributing to host-pathogen interaction
is crucial to understand the pathogenesis and dissemination of tuberculosis. This is partic-
ularly the case in deciphering the mechanistic basis for host-tropism across the MTBC.
Here, we show that in vitro, M. bovis but not M. tuberculosis induces multinucleated cell
formation in bovine macrophages. We identified host and pathogen mechanistic drivers
of multinucleated cell formation: MPB70 as the M. bovis factor and bovine macrophage
extracellular vesicles. Using a cattle experimental infection model, we confirmed differen-
tial multinucleated cell formation in vivo. Thus, we have identified host and pathogen fac-
tors that contribute to host tropism in human/bovine tuberculosis. Additionally, this
work provides an explanation for the long-standing association of multinucleated cells
with tuberculosis pathogenesis.
Introduction
Host tropism relates to the range of host species that a pathogen can sustain within, requiring
the pathogen to infect, replicate and transmit in this host. Mycobacterium tuberculosis (Mtb)
causes tuberculosis (TB) in humans and is a leading cause of morbidity and mortality world-
wide from a single infectious agent, with 1.8 million deaths in 2018 [1]. Mtb is an obligate
pathogen with distinct tropism for humans, transmitting between individuals via aerosols.
Infection generally occurs in terminal lung airways, where the bacillus is taken up by alveolar
macrophages before disseminating to other organs. Regardless of which tissues are involved,
the immune response against the bacillus progressively leads to the formation of granulomas,
where the bacilli can either disseminate from or persist [2–4].
On the other hand, bovine TB is caused by M. bovis (Mbv) and shows a broader host tro-
pism, infecting and transmitting between a variety of livestock and wildlife populations [5].
Mbv also poses a risk as a zoonotic pathogen, representing a serious threat to human health
[1]. In 2005, the WHO declared bovine TB as the most neglected zoonotic disease threatening
human health [6–8].
The genomes of Mbv and Mtb are over 99.9% identical [9]. The main genomic differences
between these two pathogens encompass 8 regions of difference (RDs) and over 2000 single-
nucleotide polymorphisms (SNPs) [9,10]. While this level of genetic difference is relatively
small, it results in major phenotypic variation that ultimately defines host tropism. Compara-
tive analysis revealed 77 and 103 genes upregulated at both the RNA and protein level in Mbv
AF2122/97 and Mtb H37Rv, relative to each other, during in vitro growth [11]. Proteins show-
ing differential abundance included known virulence factors such as EsxA, EsxB as well as the
immunogenic MPB70 and MPB83 [11–15].
In both human and bovine TB, macrophages are the first line of defence as well as one of
the main cellular reservoirs of tubercle bacilli [16]. In the lung or other organs, the progressive
establishment of a TB immune response leads to the recruitment of immune cells including
CD4+ T cells, CD8+ T cells, as well as both pro- and anti-inflammatory macrophages orga-
nized in structures called granulomas. The presence of multinucleated giant cells (MNGCs;
also called Langhans’ cells), containing 20 or more nuclei, represents an important feature of
granulomatous inflammation [2,17]. MNGCs are formed by fusion of pro-inflammatory mac-
rophages recruited at the inflammation site, and contribute to the global inflammatory
response [18,19]. MNGC formation is a multifactorial process involving cytokines such IFN-y,
IL-4, IL-3, TNF-α, IL-2, M-CSF and GM-CSF as well as other fusogenic molecules including
PLOS PATHOGENS Differing macrophage responses in human and bovine TB
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009410 March 15, 2021 2 / 31
(Username: reviewer65235@ebi.ac.uk Password:
5yBTVK8y, S2 Table).
Funding: This work was supported by the Francis
Crick Institute, which receives its core funding from
Cancer Research UK (10092 to MGG), the UK
Medical Research Council (10092 to MGG), and
the Wellcome Trust (10092 to MGG) and by the
Biotechnology and Biological Sciences Research
Council (BB/N004574/1 to MGG and SVG), Science
Foundation Ireland (SFI/15/IA/3154 to SVG) and a
Wellcome Trust PhD studentship (109166/Z/15/A
to MM), and EU FP7 Research Infrastructures
grant agreement No. FP7-228394 (NADIR to SVG).
The funders had no role in study design, data
collection and analysis, decision to publish, or
preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
carbohydrates, lipopeptide or secreted cellular factors and receptors including metalloprotei-
nases, tetraspanins, DC-STAMP and E-cadherin [19–27]. However, none of those fusogenic
factors is strictly required to induce MNGC and the process is complex. Although macrophage
differentiation and activation is crucial for MNGC formation, it is still unclear whether the
direct interaction of mycobacteria with macrophages promote MNGC formation, or if it
results from the combination of macrophage activation status with the release of specific
mycobacterial antigens [28,29].
Here, we compared two archetypal MTBC host-adapted species, Mtb H37Rv and Mbv
AF2122/97 [9,10,30] for in vitro interactions with GM-CSF monocyte-derived primary human
(hMϕ) or bovine (bMϕ) macrophages. We show that Mtb and Mbv reside in different cellular
compartments and differentially replicate in hMϕ, while both strains efficiently replicate in
bMϕ. We demonstrate that, both in vitro and in vivo, Mbv but not Mtb specifically promotes
MNGC formation in bMϕ, arguing that this host-specific MNGC generation contributes to
the contrasting pathogenesis between Mtb and Mbv in cattle. Finally, we show that the secreted
Mbv protein MPB70 and bMϕ-derived extracellular vesicles (EVs) are bacterial and host fac-
tors specifically implicated in bMϕ-multinucleation. Our results identify functional differences
between Mbv and Mtb host-pathogen interaction, disclosing a role for MPB70 and EVs in the
process of multinucleation in bovine macrophages, and revealing distinct evolutionary adapta-
tions of MTBC to specific hosts.
Results
Mtb and Mbv differentially replicate within human or bovine macrophages
In order to identify host and bacterial factors during species-specific macrophage interactions,
we set up an experimental infection model comparing, side by side, blood-derived primary
human or bovine macrophages (hMϕ and bMϕ, respectively) infected with either Mtb or Mbv.
First, we optimized the infection ratios for both macrophage models by analysing the ability of
hMϕ and bMϕ to phagocytose Mtb-RFP (Mtb-expressing Red Fluorescent Protein) or Mbv-
RFP. After 2 h, we observed that Mtb-RFP and Mbv-RFP uptake was similar in both hMϕ or
bMϕ. However, bacterial uptake was approximately 10 times higher in bMϕ when compared
to hMϕ. In order to normalize the infection protocol, we then infected bMϕ with a lower MOI
(MOI of 1) than hMϕ (MOI of 10) (S1A Fig). Following infection, Mtb and Mbv replication in
hMϕ and bMϕ were quantified microscopically after 72 h of infection (Fig 1A). In hMϕ, Mtb
replicated as previously shown [31] whereas Mbv replication was delayed (Fig 1B). In contrast,
both Mtb and Mbv replicated at similar rates in bMϕ up to 72 h (Fig 1C). After 72 h of infec-
tion, there was cytotoxicity associated with bMϕ but not hMϕ (S1B and S1C Fig). In hMϕ,
cytotoxicity was detectable after 5 days of infection with Mtb, while a significant number of
hMϕ infected with Mbv was still detectable (S1C Fig). Next, we assessed the cytotoxicity of
Mtb in hMϕ using the cell death reporter Green Live/Dead (S1D Fig). After 5 days of infection,
Mtb actively replicated in hMϕ and was associated with cell death while Mbv slowly replicated
in hMϕ with limited cell death (S1D Fig). We then infected hMϕ at a low MOI (MOI 2) with
Mtb-RFP and Mbv-RFP for 8 days and found that Mbv replication significantly increased after
8 days of infection compared to the basal uptake observed 2 h post-infection (S1E Fig). Thus,
the progression of Mbv-intracellular replication in hMϕ suggests that, although Mbv replica-
tion is restricted compared to Mtb, hMϕ failed to completely eradicate the infection.
Intracellular localization of Mtb and Mbv differs in human macrophages
Next, we tested whether the different bacterial replication rates were associated with a differen-
tial ability of Mtb or Mbv to evade host macrophage restriction. Although both hMϕ and bMϕ
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Fig 1. Mtb and Mbv differentially replicate and localise within human or bovine macrophages. (A) Confocal images of monocyte-derived GM-CSF
differentiated-human or bovine Mϕ (hMϕ or bMϕ) infected with RFP-expressing M. tuberculosis H37Rv (Mtb-RFP) or M. bovis (Mbv-RFP) for 2, 24 and 72 h.
Brightfield was used to visualize the cells. Cell nuclei were stained with DAPI (blue) and bacteria-RFP are visualized in red. Scale bar: 20 μm. (B and C)
Quantification of intracellular growth expressed in bacteria area (μm2) per infected cell of Mtb-RFP and Mbv-RFP within hMϕ (B) and bMϕ (C). (D and E) Electron
microscopy images of hMϕ (D) and bMϕ (E) infected with Mtb or Mbv for 24 h. Asterisks mark the intracellular bacteria. Images were selected to illustrate free
cytosolic bacteria (left-hand panels), phagosomal bacteria (middle panels) and bacteria surrounded by multiple membranes (right-hand panels). Scale bar, 200 nm.
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were produced with a similar method, electron microscopy analysis showed that the cytoplasm
of resting bMϕ was strongly enriched with spacious single-membrane vesicles when compared
to hMϕ (S1F Fig). These large vacuoles were positive for the late endosomal marker, LAMP-1
(S1G Fig). Whereas in hMϕ the localisation of intracellular mycobacteria is relatively well
characterised [16,32], the localisation of Mbv in bMϕ is unknown. We therefore quantified the
percentage of bacteria associated with (i) the late endosomal marker LAMP-1, (ii) the pH-sen-
sitive Dye Lysotracker Red (LTR) or (iii) the autophagosome marker LC3B, after 24 h of infec-
tion (S2 Fig). For this, we used two different approaches to quantify the localisation: one for
markers closely associated with bacteria [33] and another method for spacious compartments
such as the LAMP-1 positive phagosomes [34]. In hMϕ, 37% ± 14.7 and 39% ± 11.9 of Mtb
and Mbv respectively were found associated with LAMP-1. Similarly, in bMϕ, 45% ± 9.4 and
36% ± 5.4 of Mtb and Mbv, respectively, were found in a LAMP-1-positive vacuole. The high
level of bacterial association with the LAMP-1 marker suggests that, in both species, a signifi-
cant fraction of the bacteria is membrane-bound (S2A and S2B Fig). In contrast, only 15 to
20% were found associated with lysotracker in both hMϕ and bMϕ, suggesting that, indepen-
dent of the host species, a limited proportion of membrane-bound mycobacteria were in acidic
compartments after 24 h of infection (S2C and S2D Fig).
In hMϕ, LC3B was found associated with 28% ± 6.06 of Mbv, while only 10% ± 0.86 of Mtb
was positive for this autophagosome marker (S2E Fig). Autophagy is an anti-mycobacteria
pathway [35–37] and the higher association of Mbv with LC3B-positive compartments may
explain the delayed intracellular replication. However, Mtb and Mbv presented a similar asso-
ciation with LC3B or all the other markers tested in bMϕ (S2F Fig). Next, we analysed the loca-
lisation of mycobacteria at the ultrastructural level and defined the proportion of bacteria
localised in (i) a single-membrane phagosome, (ii) in a multi-membrane vacuole or (iii) cyto-
solic (Fig 1D-1F). In hMϕ, circa 40% of the Mtb population was localised in the cytosol. Mtb
also resided in a single-membrane compartment (>55%) and a minor proportion in multi-
membrane compartments (<5%) (Fig 1D and 1F). In contrast, the majority of Mbv were local-
ized in single- and multi-membrane compartments (>75% and around 20%, respectively) and
only a minority of Mbv was localised in the cytosol (<5%) (Fig 1D and 1F). On the other
hand, in bMϕ, the majority of Mtb localised in the cytosol (around 75%) whilst the rest mainly
resided in a single-membrane compartment (Fig 1E and 1F). Moreover, Mbv was associated
with single-membrane compartments and also localised in the cytosol of bMϕ (Fig 1E and 1F).
Given that cytosolic DNA will trigger expression of interferon-β (IFNβ) [36,38,39], we moni-
tored by RT-qPCR the expression of IFNB in hMϕ and bMϕ infected with Mtb or Mbv. We
found that Mtb induced higher IFN-β levels than Mbv in hMϕ and bMϕ, confirming that,
regardless of species, Mtb accessed the cytosol more efficiently than Mbv (Fig 1G).
Mbv specifically induces the formation of multinucleated giant cells
(MNGCs) in bMϕ
The similar features observed for both pathogens during infection of bMϕ did not reflect the
attenuated phenotype of Mtb seen in cattle [40]. However, we noticed that the fusogenic prop-
erties of bMϕ were different after infection with either Mtb-RFP or Mbv-RFP. As early as 24 h
(F) Quantification by stereology of the proportion of bacteria contained in each compartment. Black represents the proportion of cytosolic bacteria; green, the
proportion of single membrane bound bacteria, and grey, the bacteria surrounded by multiple membranes. “n” represents the number of cells analysed. The total
number of bacteria analysed corresponds to the number in brackets. (G) Quantification by RT-qPCR of the relative fold change mRNA expression of interferon-β
(IFNB1) in hMϕ (left graph) and bMϕ (right graph) infected with Mtb or Mbv for 24 h. Data are normalized to Mtb. (Housekeeping gene used: GAPDH). Non-
infected cells (NI) were use as control. For all the figures, p-value is considered significant when< 0.05 and indicate as follow: �p<0.05; �� p<0.01; ��� p<0.001; ns:
not significant.
https://doi.org/10.1371/journal.ppat.1009410.g001
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post-infection, bMϕ tended to form multinucleated giant cells (MNGCs) especially when
infected with Mbv (Fig 2A). A quantitative analysis of MNGC numbers confirmed that
Mbv infection induced more MNGCs when compared to Mtb-infected or non-infected
(NI) cells (Fig 2B). Multinucleation of bMϕ occurred only with live bacteria since parafor-
maldehyde-killed-Mbv (PFA-Mbv) showed similar numbers of MNGCs to both Mtb-
infected and uninfected Mϕ (S3A and S3B Fig). This effect was restricted to bMϕ, since
MNGCs were almost absent in hMϕ infected either with Mtb or Mbv (Fig 2C). Impor-
tantly, Mbv-infected bMϕ showed a broad range of nuclei associated with an increase of
cell size (S3C Fig). In contrast, the limited number of multinucleated hMϕ detected were
Fig 2. Mbv specifically induces the formation of MNGCs in bMϕ. (A) Fluorescence confocal images of bMϕ infected with Mtb-RFP or Mbv-RFP for 24 h. Non-
infected cells (NI) were used as a control. The bacteria are visualized in red, the cell actin cytoskeleton is in white (phalloidin-488) and cell nuclei (DAPI) in cyan.
Arrows highlight the cells containing 2 or more nuclei, corresponding to multinucleated giant cells (MNGCs). Scale bar, 50 μm. (B) Quantification of the percentage
of MNGCs in bMϕ infected with Mtb-RFP or Mbv-RFP for 24 hours. Non-infected cells (NI) were used as a control. Each dot represents one donor tested. (C)
Quantification of the percentage of MNGCs in hMϕ infected with Mtb-RFP or Mbv-RFP for 24 h. Non-infected cells (NI) were used as a control. (D) Electron
microscopy image of an uninfected bystander-MNGC containing four distinct nuclei (marked by red arrows). The images displayed on the right side correspond to
the magnification of each region (a-c) delimited by black squares in the main image. Scale bar are D: 40 μm; Da: 2 μm; Db: 2 μm; Dc: 1 μm. (E) Maximum projection
(14 Z-stacks with an interval of 0.8 μm) from confocal images of bovine MNGCs without intracellular Mbv-RFP (Byst-MNGC) or containing intracellular Mbv-RFP
(Mbv-MNGC). In the latter image, the presence of intracellular bacteria is highlighted in the region delimited by a white square, magnified in the right corner.
Bacteria are visualized in red, the cells with brightfield image, and nuclei in cyan. A dashed line delimits the edge of MNGCs. (F) Quantification of the percentage of
bystander and Mbv-MNGCs in the bMϕ population for two independent donors. Each bar chart represents the total MNGC population (100%); in black is
percentage of Mbv-infected MNGCs, and in grey the percentage of uninfected bystander-MNGCs.
https://doi.org/10.1371/journal.ppat.1009410.g002
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mostly binucleated with a small variation of cell size (S3C Fig). At the ultrastructural level,
we confirmed that the multiple nuclei were contained in a single cell (Figs 2D and S3D).
MNGCs were significantly larger than mononucleated bMϕ and contained a central vesi-
cle-rich area surrounded by intact nuclei (Fig 2D). Although the number of nuclei was vari-
able, their circular alignment at the periphery of the cytosol was reminiscent of the
morphology of the multinucleated giant cells (also called Langhans’ cells) present in granu-
lomatous lesions (Figs 2D and S3D). Altogether, these data suggest that as early as 24 h post
infection, Mbv interactions with bMϕ induces the formation of MNGCs. Importantly, 54
and 58% of MNGCs observed by fluorescence microscopy were uninfected, suggesting a
bystander effect (Fig 2E and 2F). To test this possibility, we stimulated naïve bMϕ with fil-
tered supernatant from infected-bMϕ. Only supernatants from Mbv-infected bMϕ led to a
significant increase in MNGC formation when compared to supernatants from non-
infected or Mtb-infected bMϕ (S4A Fig). In agreement with a species-specific phenotype,
supernatants from hMϕ infected with either Mtb or Mbv failed to induce multinucleation
in bMϕ (S4A Fig). These results demonstrate that factors present in the extracellular
medium contribute to multinucleation in bMϕ. The factor(s) responsible for cell multinu-
cleation were proteinaceous since heat-inactivated supernatant did not induce MNGC for-
mation (S4A Fig). Similar experiments in infected hMϕ showed that none of the
conditions tested increased the number of MNGCs (S4B Fig). These data show that pro-
teins secreted by bMϕ after infection with Mbv induced MNGC formation.
Secreted bacterial MPB70 contributes to MNGC formation in bMϕ
One of the main differences between Mbv and Mtb is the level of expression of genes in the
SigK regulon that encode secreted proteins such as MPB70. The gene encoding MPB70 is
highly expressed by Mbv, whereas its expression is low in Mtb in vitro but shows intracellular
induction [41]. Furthermore, MPB70 contains a FAS1-domain, a structure that is known to
play a role in cell adhesion [42,43]. Hence, we hypothesised that MPB70 induces multinuclea-
tion during Mbv macrophage infections [11,14,44,45]. To investigate whether MPB70 affects
bMϕ multinucleation, we generated an Mbv strain with the gene encoding MPB70 deleted
(Mbv ΔMPB70) and the complemented strain (Mbv-Compl) (Figs 3A and 3B and S5). As
expected, deletion of the MPB70 gene completely abolished the secretion of MPB70 in Mbv
ΔMPB70 compared to Mbv wild type (Mbv WT) and Mbv-Compl (Fig 3A). Next, we infected
bMϕ with Mbv WT, Mbv ΔMPB70 or Mbv-Compl and analysed the numbers of MNGCs after
24 h of infection (Fig 3B). We found that the deletion of MPB70 markedly impaired the ability
of Mbv to induce multinucleation. In agreement with MPB70 having a role in the multinuclea-
tion process, infection with Mbv-Compl induced MNGC formation at similar levels to that of
Mbv WT infection (Fig 3C). We concluded that MNGC formation in bMϕ is a specific
response to MPB70 activity after Mbv infection.
MPT70 (homologous to MPB70 in human-adapted strains) is expressed at a very low level
by Mtb strains [11,14]. We then examined whether MPB70/MPT70 itself controled MNGC
formation or whether other factors were required for bMϕ multinucleation. For this, we gener-
ated an Mtb strain constitutively expressing MPT70 (Mtb-MPT70+; S5E and S5F Fig). Next,
we infected bMϕ with Mbv WT, Mtb WT or Mtb-MPT70+ for 24 h, and analysed the numbers
of MNGCs (Fig 3D and 3E). As observed before, Mbv WT induced MNGCs and the number
of MNGCs was significantly higher in bMϕ. Interestingly, the number of MNGCs in bMϕ
infected Mtb-MPT70+ remained similar to that counted in both uninfected or Mtb WT
infected cells (Fig 3D and 3E). This suggests that, unlike Mtb, Mbv induces a specific bMϕ
response, which together with MPB70 expression enables the formation of MNGCs.
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Fig 3. Secreted bacterial MPB70 contributes to MNGC formation in bMϕ. (A) Culture filtrate from Mbv wild-type
(WT), Mbv ΔMPB70, Mbv ΔMPB70/MPB70 (Mbv-Compl.) were assessed for immuno-labelling of MPB70 (23 kDa).
Immuno-labelling of Ag85 (38 kDa) was used as gel loading control (B) Fluorescence confocal images of bMϕ infected
PLOS PATHOGENS Differing macrophage responses in human and bovine TB
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Extracellular vesicles from Mbv-infected bMϕ promote MNGC formation
To identify the host factors involved in bMϕ multinucleation, we analysed the secretome of
Mtb- versus Mbv-infected bMϕ. We identified 1341 host proteins in the cell-free supernatants
and found that 192 proteins showed differential abundance between mycobacteria-infected
bMϕ and uninfected control samples by mass spectrometry-based proteomics (Fig 4A and S1
and S2 Tables). Notably, the majority of the identified proteins were associated with extracellu-
lar vesicle (EVs) biogenesis and trafficking, cellular focal adhesion or membrane trafficking
(Fig 4A). Furthermore, 27 proteins were found to be differentially secreted between Mtb- and
Mbv-infected bMϕ (Fig 4B and S1 and S2 Tables). Given the marked presence of an EV-associ-
ated signature in the proteomic analysis, we hypothesized that EVs released during infection
might contribute to bMϕ multinucleation. To test this, we isolated EVs and assessed the qual-
ity and purity of the EV-enriched fractions by electron microscopy (Fig 4C and 4D). Naïve
bMϕ were then stimulated for 24 h with the EV-enriched fraction from uninfected (NI), Mtb-
or Mbv- infected bMϕ, or with PBS as a negative control. The percentage of MNGCs signifi-
cantly increased in bMϕ stimulated with the EV fraction from Mbv-infected bMϕ, whereas the
EVs from Mtb-infected bMϕ did not induce significant MNGC formation (Fig 4E and 4F).
Altogether, our data suggest that Mbv-induced EVs contribute to bMϕ multinucleation by act-
ing as carrier for the transport and delivery, to targeted cells, of key components involved in
the multinucleation process.
Granulomas from Mbv-infected cattle contain a higher number of MNGCs
than Mtb-infected cattle
Inflammation occurring within granulomatous lesions leads to the formation of specific multi-
nucleated cells, called Langhans’ cells. Our in vitro data suggested that cattle infected with Mbv
or Mtb should show variation in Langhans’ cells in vivo. Post-mortem histopathological analy-
sis was performed on H&E stained thoracic lymph node (LN) sections from cattle infected
with Mtb H37Rv for 10 weeks or with Mbv AF2122/97 for 6 weeks. Limited numbers of granu-
lomas were detected in LNs from cows infected with Mtb (Fig 5). In agreement with previously
described studies [40,46], Mtb-induced granulomas were at an early stage of maturation (type
I and II as described by [47,48]), with limited traces of necrosis or caseification (Fig 5A and
5C). In contrast, LNs from cows infected with Mbv contained a large number of granuloma-
tous lesions at all stages of maturation (Fig 5B and 5C).
In agreement with the in vitro data, we found that the number of MNGCs present in Mtb-
induced granulomas was significantly lower than in Mbv-induced granulomas (Fig 5A, 5B and
5E). It is noteworthy that for a similar amount of Acid Fast-positive Bacilli (AFB) detected in
stage II granulomas from both Mtb- and Mbv-infected cows (Fig 5D), Mbv-infected granulo-
mas contained around 2.5 times more MNGCs compared to Mtb-infected granulomas (Fig
5E). Moreover, the number of MNGCs increased during granuloma maturation, suggesting
with Mbv WT, Mbv ΔMPB70, Mbv-Compl. for 24 h. Uninfected cells had been used as a negative control. Cell nuclei
are stained with DAPI (cyan) and actin is visualized in grey. Yellow arrows point the multi-nucleated cells. Scale bar,
50 μm (C) Quantification of MNGCs from each experiment displayed in B. Graph represents the quantification of
MNGCs for each condition tested where each dot represents one bovine donor. Data shown are representative of four
biological repeats. (D) Fluorescence confocal images of bMϕ infected with Mbv WT, Mtb, Mtb-MPB70+ for 24 h.
Uninfected cells had been used as a negative control. Cell nuclei were stained with DAPI (cyan); bacteria-RFP and actin
are visualized in red and grey, respectively. Yellow arrows point the multi-nucleated cells. Scale bar, 50 μm (E)
Quantification of MNGCs from each experiment displayed in D. Graph represents the quantification of MNGCs for
each condition tested where each dot represents one bovine donor. Data shown are representative of two independent
experiments.
https://doi.org/10.1371/journal.ppat.1009410.g003
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that the expansion of the MNGC population correlates with the severity of granulomatous
inflammation.
Matured MNGCs provide a restrictive environment for M. bovis
In our model of bovine Mϕ, the MNGC population is heterogeneous, with cells showing dif-
ferent sizes and numbers of nuclei. A previous study reported that the differentiation pro-
cess modified the anti-mycobacterial phenotype of MNGCs [29]. To define the effect of
bovine Mϕ multinucleation on Mbv, we differentially evaluated the intracellular trafficking
of Mbv in mononucleated cells, early MNGCs (containing 2–3 nuclei) or mature MNGCs
(containing over 3 nuclei). First, we analysed Mbv intracellular burden in these three pre-
defined cellular populations. Mononucleated and bi or tri-nucleated giant cells (defined as
early MNGC) harboured a similar proportion of intracellular single bacteria as well as large
bacterial clusters (Fig 6A). In contrast, MNGCs containing more than three nuclei (defined
as mature) showed a significantly lower bacterial burden, mostly composed of single or
small bacterial groups (Fig 6A). This suggests that mature MNGCs are either less permissive
to Mbv and/or provide a more restrictive environment, limiting bacterial spread. In order
to evaluate the nature of the intracellular environment encountered by Mbv in MNGCs, we
analysed the intracellular localisation of Mbv in the three different macrophage populations.
Interestingly, both mononucleated bMϕ and early MNGCs showed a similar proportion of
Mbv positive for the lysosomotropic dye Lysotracker (LTR), indicating that the process of
lysosomal acidification is maintained during the first stage of MNGC formation. Con-
versely, in mature MNGC, a significantly higher proportion of Mbv were localised in LTR
positive compartments (Fig 6B). We next evaluated the proteolytic activity in the three
defined Mϕ populations using the pan cysteine-cathepsin activity-based probe BMV109.
Although the global cathepsin activity was high, we did not observe significant differences
between the populations (Fig 6C). Because autophagy is a major anti-bacterial pathway, we
finally monitored LC3B association with intracellular Mbv. As observed for acidification,
LC3B association with Mbv was similar in both mononucleated bMϕ and early MNGCs but
increased in mature MNGCs (Fig 6D).
We concluded that the major lysosomal degradative pathways remain functional during
MNGC differentiation. Additionally, the increase of Mbv in acidified compartments and asso-
ciation with LC3B in mature MNGCs suggest that MNGCs present a more restrictive milieu
for mycobacterial proliferation.
Discussion
In this work, by analysing infections of Mϕ from two host species with two host-adapted
mycobacteria, we shed new light on species-specific host-pathogen interactions in tuberculo-
sis. When comparing the Mϕ infections side-by-side, unexpectedly, there were no striking
Fig 4. Extracellular vesicles produced by Mbv-infected bMϕ induce cell multinucleation. (A) A total of 192 proteins were determined to be differentially
regulated using an ANOVA and Tukey’s post-hoc test in the secretome of infected bMϕ and sorted according to Gene Ontology Cellular Component (GOCC).
(B) List of 27 proteins differentially expressed in the secretome of Mtb-infected or Mbv-infected bMϕ clustered into 3 groups: extracellular vesicles, membrane
trafficking and cell adhesion or others. The log2 fold change Mtb or Mbv, both normalised to uninfected (NI), samples are displayed in the left panel and the log2
fold change Mbv/Mtb is displayed in the right panel. Proteomics data were obtained from 3 independent experiments carried out with 3 different bovine donors.
(C) EV purification procedure summarized in 3 steps. (D) Electron microscopy micrographs of EV-enriched fraction. The white arrows show the extracellular
vesicles. Scale bar: 0.1 μm. (E) Fluorescence confocal images of naïve bMϕ stimulated for 24 h with EV-enriched fraction from uninfected (NI), Mtb-infected or
Mbv-infected bMϕ. As EVs were purified in PBS, a similar volume of PBS was added to the bMϕ as a control. Cell nuclei are stained with DAPI (cyan) and actin
is visualized in grey. Yellow arrows point the MNGCs. Scale bar: 50 μm (F) Quantification of MNGCs after bMϕ stimulation with EV-enriched fractions. The
graph represents the quantification of MNGCs for each condition tested where each dot represents one bovine donor. Data are representative of 4 independent
experiments.
https://doi.org/10.1371/journal.ppat.1009410.g004
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species-specific differences in bacterial replication that could explain host tropism in human
and bovine TB. Mtb replicates more efficiently than Mbv in hMϕ, while both pathogens repli-
cated similarly in bMϕ. These differences could be related to the differentiation protocols and
more studies are needed to identify the possible differentiation factors implicated. Neverthe-
less, both Mtb and Mbv showed similar uptake in each Mϕ species, suggesting that despite the
interspecies differences, both Mtb and Mbv are similarly recognized by macrophage receptors.
Mtb produces MNGCs in human disease and animal models, but the underlying mecha-
nisms remain unclear. Here we show that both in vitro and in vivo the specific interaction
between Mbv and the bovine host led to the formation of MNGCs, arguing that both host and
pathogen factors are required for MNGC formation. Because the production and secretion of
the mycobacterial protein MPB70 is one of the main phenotypic differences between Mbv and
Mtb [14], this protein was an obvious candidate. Moreover, MPB70 has homology with the
cell adhesion domain Fasciclin 1 (FAS1), Osteoblast-specific factor II (OSFII) or βIgH3, sug-
gesting that MPB70 could mediate cell-to-cell contact or cellular adhesion by interacting with
cellular receptors such as stabilins, integrins, as well as extracellular matrix components
[42,43]. Cell-adhesion is a crucial step in the fusion process, bringing Mϕ into close contact
with extracellular matrix components. It is tempting to speculate that MPB70 is implicated in
bMϕ fusion by mediating cellular interactions and adhesion properties. The differential
expression of MPB70 between both pathogens may also partially explain the inability of Mtb
to induce MNGCs in our in vitro model. On this latter point, further studies are needed to
explore the kinetics of MNGC formation in vitro and if, or how, Mtb can be modified to
induce bMϕ MNGC formation. Although MPB70 expression is low in Mtb, its expression may
increase in stress conditions such as exposure to antibiotics or depending on the Mϕ lineage in
which the pathogen resides [49,50]. The MPB70 homologous protein MPT70 is thus likely
secreted by M. tuberculosis and locally accumulates during human TB progression, contribut-
ing to the formation of MNGCs in human TB. The observed reduced levels of MNGCs in
granulomas from cattle infected with Mtb as compared to Mbv further indicates that multinu-
cleation requires both host and pathogen factors.
Macrophage fusion is a rare event that occurs in distinct environments [51]. The first study
of MNGC formation in culture showed that human monocytes could differentiate into
MNGCs when exposed to certain microenvironments [52]. Since then, numerous cytokines
had been identified as potent inducers of MNGCs [21,23–25,53]. In most experimental models
using monocytes, MNGC formation occurred after several days of exposure to fusogenic fac-
tors such as IL-4, suggesting that monocytes need to mature in order to acquire fusogenic
properties [25,54]. In contrast, certain populations of primary Mϕ alternatively activated by
IL-4 can induce MNGC formation relatively rapidly (i.e. in hours) when exposed to additional
pro-fusogenic stimuli [21]. Thus, the fusogenic properties of Mϕ rely on multiple components,
which include a specific inflammatory phenotype together with contact with other fusion part-
ners. As MNGCs mostly originate from inflammatory Mϕ [18], we used a model of GM-CSF-
derived Mϕ. We showed here that GM-CSF bMϕ are competent to generate MNGCs specifi-
cally in response to Mbv infection. However, neither Mtb nor Mbv trigger MNGC formation
Fig 5. Granulomas from Mbv-infected cattle contain a higher number of MNGCs than Mtb-infected cattle. (A, left image) Histological
Haematoxylin and Eosin (H&E) staining of granulomatous lesions in thoracic lymph nodes of cattle challenged for 10 weeks with Mtb H37Rv
strains. Scale bar, 200 μm. (A, right image) higher magnification of multinucleated giant cells (white square). Scale bar, 50 μm. (B, left image) H&E
staining of granulomatous lesions in thoracic lymph nodes of cattle challenged for 6 weeks with Mbv AF2122/97. Scale bar, 200 μm. (B, right
image) higher magnification of multinucleated giant cells (white square). Scale bar, 50 μm. (A and B) Granulomas are classified from early stage of
maturation (type I and II) to late granulomas (type III and IV) (C) Quantification of the number of granulomas counted for each condition. (D)
Quantification of bacterial load in each granuloma based on acid fast staining of the tissue section and expressed as the mean Acid Fast Bacilli
(AFB) ± SEM. (E) Quantification of the number of MNGCs per granuloma ± SEM.
https://doi.org/10.1371/journal.ppat.1009410.g005
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in hMϕ. We speculate that in the context of human granuloma, MNGCs possibly originate
from another subpopulation of activated Mϕ recruited during TB inflammation.
Our results that GM-CSF-derived bMϕ multinucleation is driven by factors released into
the extracellular milieu after Mbv infection suggested a host factor was also involved. In this
context, the extracellular microenvironment plays an important role in Mϕ fusion and MNGC
formation. The cell density, the nature of the extracellular matrix, and the local concentration
of growth factors, chemokines or cytokines are important factors for cell differentiation, cell-
to-cell contact and membrane fusion [55–57]. In agreement with this notion, the Mbv-infected
bMϕ secretome analysis revealed a dominant signature of proteins related to cell-adhesion,
membrane trafficking, and extracellular vesicles. Extracellular vesicles and exosomes play a
crucial role in cell communication, inflammation, and are implicated in multiple infectious
diseases [58]. During Mtb infection, extracellular vesicles participate in the inflammation pro-
cess through the recruitment of Mϕ to the site of infection, the modulation of immune
responses, antigen presentation, and/or transport of bacterial components [59–62]. Exosomes
from murine J774 macrophages infected with Mtb contained several antigenic bacterial pro-
teins such as EsxA, EsxB, SapM, PknG as well as MPT32, MPT53, MPT63 and MPT64 [59].
We speculate that EVs modulate cell multinucleation by acting as carriers for the transport of
host and bacterial factors that will promote multinucleation. In our proteomics approach, we
were not able to detect Mtb proteins and complementary approaches with increased sensitivity
are needed for the identification of bacterial factors present in the supernatants. In vivo, when
released, these vesicles may then traffic towards the tissue to another site such as the periphery
of granulomas, interact with resident or recruited Mϕ, and promote the formation of MNGCs.
During TB inflammation, Mϕ fusion occurs during granuloma progression leading to
MNGCs or Langhans’ cells [17,63]. Generally, Langhans’ cells are localised at the peripheral
epithelioid rim of the granuloma and can contain around 20 nuclei. Langhans cells, associated
with granulomatous lesions, are derived from pro-inflammatory macrophages (CD68+, CD40
+, DC-STAMP+), which fuse in response to inflammatory stimuli such as macrophage-colony
stimulating factor (M-CSF), Tumour necrosis factor-α (TNF- α) or interferon-γ (IFN- γ)
[18,27,64,65]. Although the role of MNGCs in the granuloma is still unclear, several studies
suggest a role of these cells in inflammation and bacterial control (reviewed in [18,66]).
MNGCs can indeed take up large targets for degradation [67] and when they mature and lose
their ability to uptake bacteria, the remaining NADH oxidase activity and antigen presentation
clear all pathogens already inside [29]. Consistently, we found that mature MNGCs contained
very low numbers of mycobacteria that were localised in acidic compartments with autophagic
Fig 6. MNGCs provide a restrictive environment for Mbv. (A) (upper panel) Tile scan of 3 successive confocal images
showing the diversity of bMφ infected with Mbv-GFP for 24 h. Cells were fixed and immunolabelled for LAMP-1 (red),
Mbv-GFP (green) and cell nuclei in blue (DAPI). The lower panel represents a crop of the region marked by a white
square. The different cell population are marked as follow: �Mono: Mononucleated cells; ��MNGC (early):
Multinucleated cells with 2 or 3 nuclei; ���MNGC (mature): Multinucleated cells with over than 3 nuclei. Right panel:
the quantification of the intracellular bacterial load in mononucleated and early or mature multinucleated cells is
expressed in bacteria area per cell area. (Mono, n = 60 cells; MNGC (early), n = 22 cells; MNGC (mature), n = 28 cells).
(B, C, D) bMφ infected with Mbv-GFP (displayed in green) for 24 h were stained with (B) LysoTracker Red (LTR, in
red), (C) the pan cysteine-cathepsin activity-based probe BMV109 (in grey) and (D) immuno-labelled with a LC3B
antibody (in red). DAPI was used to label nuclei (in blue). (B) LTR (number of bacterial object analysed (n)); Mono,
n = 633; MNGC (early), n = 80; MNGC (mature), n = 88). (C) BMV109; Mono, n = 368; MNGC (early), n = 52; MNGC
(mature), n = 76). (D) LC3B; Mono, n = 1374; MNGC (early), n = 243; MNGC (mature), n = 133). Each micrograph is a
representative image of mononucleated cells (Mono), multinucleated giant cells (MNGC) with 2 or 3 nuclei (early) or
over 3 nuclei (mature). The lower panels correspond to a zoom of the region marked by a white square. The
quantification of each marker’s association with bacteria is shown on the right panels. The dashed lines show the
fluorescence cut-off applied. The data are representative from two independent experiments from 2–3 donors.
https://doi.org/10.1371/journal.ppat.1009410.g006
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features. Therefore, it is likely that during formation, MNGC evolve toward a more restrictive
environment for intracellular mycobacteria.
Mtb has previously been isolated from lesions found in naturally infected cattle [68–71].
These latter cases show that, in certain circumstances, Mtb can cause disease in cattle, an out-
come that may depend on the genetic background of both the infecting strain and host, as well
as host immune status. This underlines the need to unravel the mechanistic basis for MNGC
formation in well controlled experimental systems. In a head-to-head experimental cattle
infection, we have previously shown that two Mtb strains, the hallmark Mtb H37Rv and an
Mtb isolated from a bull in Ethiopia (Mtb BTB1558) were attenuated in cattle as compared to
Mbv AF2122/97, with the latter inducing greater inflammation and pathology [11,40]. Here
we found that, even when the amounts of bacteria are comparable, Mbv induces a higher num-
ber of MNGCs per granuloma than Mtb, including the early-stage type I and type II granulo-
mas. This suggests that the intensity of the inflammatory response in vivo influences not only
granuloma maturation but also the formation of MNGCs. Reduction of inflammation by treat-
ment with anti-inflammatory IL-10 has been shown to reduce both granulomatous inflamma-
tion and MNGC formation [72]. Additionally, assessment of cytokine expression of MNGCs
in cattle infected with Mbv showed a correlation between the expression of pro-inflammatory
cytokines and the severity of granulomatous lesions [73]. The higher presence of MNGCs in
Mbv thus correlates with its virulent phenotype in cattle, suggesting a role for MNGCs in
inflammation, granuloma maturation and severity of TB lesions.
Altogether, our data provide evidence that a combination of bacterial effectors and species-
specific responses shapes the singular interaction of the pathogen with its host, in this instance
triggering the formation of MNGC, one of the cellular hallmarks of granulomas.
Methods
Ethics statement
Holstein Friesian cows housed at the RVC Boltons Park Farm (Hertfordshire, UK) were used
to obtain blood for PBMC isolation and subsequent Mϕ generation. Animals were held at the
RVC under certificate of designation. Animals were dewormed regularly, checked regularly
for the presence of BVD and IBR, which can both infect bMϕ, leading to immunosuppression.
Furthermore, all animals were negative for bovine TB using BOVIGAM IFN Gamma Test,
which was conducted in addition to the standard tuberculin skin test. All study cows received
a physical examination, including assessment of the respiratory, cardiovascular, gastrointesti-
nal, musculoskeletal, and reproductive systems, as well as skin, udder, and teats. The physical
examination included BCS, pulse rate, respiration rate, and a rectal temperature conducted by
a licensed veterinarian or trained designee. To avoid influences on cellular function through
various stages in the reproductive cycle, animals used were age- and lactation-matched (2nd or
3rd lactation, respectively), and were in mid-lactation. All procedures were carried under
Home Office Project licence (PPL7009059), after approval by the RVC’s Ethics and Welfare
Committee. Furthermore, handling of cows and blood sampling were conducted in accor-
dance with EU legislation (Directive 2010/63/UE, related to the protection of animals used for
scientific goals).
Reagents and antibodies
Recombinant human Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and
bovine GM-CSF were provided by Miltenyi (#130-093-867) and Abcam (#ab209168), respec-
tively. DAPI was used to stain cell nuclei and was purchased from Sigma-Aldrich (#D9542)
and the Alexa Fluor-488 Phalloidin was from Invitrogen (#A12379). Detection of cell death
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was visualized using Live/Dead Green dye (ImmunoChemistry #6342). Immunolabelling of
LC3B and LAMP-1 was performed using a rabbit anti-LC3B from Enzo Lifesciences
(MBL-PM036) and a rabbit anti-LAMP-1 from Abcam (Ab24170). Mouse antibody to MPB70
(#LAB-0007a2) and the Mouse antibody to Ag85 (#ab36731) were purchased from Lionex
GmbH and Abcam, respectively. The secondary antibodies used in this study were: goat anti-
rabbit conjugated with Alexa Fluor 488 (#A11034), (ii) goat anti-mouse conjugated with Alexa
Fluor 488 (#A11029), both purchased from Life technologies and (iii) an anti-mouse conju-
gated with HRP (#W402B) from Promega. LysoTracker Red DND-99 was from Thermofisher
scientific (#L7528) and the cysteine cathepsin activity was determined using BMV109 (iABP
Pan cathepsin (Cathepsin B/L/S/X)) from Vergent Bioscience (#40200). For light or electron
microscopy, cells were fixed using Paraformaldehyde (PFA) from Electron Microscopy Sci-
ences (#15710) or Glutaraldehyde from Sigma-Aldrich (#G5882), respectively.
Mycobacterial strains
In the study, we used the sequenced and annotated M. tuberculosis H37Rv (Mtb) and M. bovis
AF2122/97 (Mbv) reference strains as models [9,10,30]. Fluorescent Mtb and Mbv were engi-
neered to constitutively express Red fluorescent proteins (RFP) encoded by the plasmid
pML2570 integrated into the bacterial genome (Integrase: Giles, Resistance: Hygromycin).
Mbv wild type (WT), Mbv mpb70 knock-out (Mbv ΔMPB70) and the Mbv ΔMPB70 comple-
mented strains (Mbv-compl) were used in this study. Mbv ΔMPB70 cloning and complemen-
tation are detailed in the paragraph “Cloning and characterisation of Mbv 2122/97 mpb70
knock-out and complemented strains”. Mtb strains were grown in 7H9 Middlebrook broth
supplemented with 10% Albumin Dextrose Catalase (ADC), 0.05% Tween 80 and 0.5% glyc-
erol. All Mbv strains were grown in 7H9 Middlebrook supplemented with 10% ADC, 0.05%
Tween 80 and 40 mM sodium pyruvate. When required, selective antibiotics were added to
the medium (S3 Table).
Cloning and characterisation of Mbv 2122/97 mpb70 knock-out and
complemented strains
Cloning strategy. A knockout mutant in the mpb70 gene (Mb2900) of Mbv 2122/97 was
constructed using the phAE159 shuttle phasmid. One kb regions flanking the chromosomal
Mbv mpb70 were cloned into phAE159 so as to flank a hygromycin resistance marker to gener-
ate the allelic exchange substrate (S5A Fig and S3 Table). After amplification in M. smegmatis
mc2155, recombinant phages were used to infect Mbv wild type and hygromycin resistant
Mbv ΔMPB70 transductants were selected. In the deletion mutant complementation was
achieved by expression of the wild type mpb70 gene from the replicating plasmid pEW70c2
(Mbv ΔMBP70::MBP70). In Mtb-H37Rv, mpt70 from H37Rv was inserted in the plasmid
pGM221-1. MPT70 constitutive expression is under the control of the hsp60 promoter from
the mycobacterial replicative plasmid pGM221-1 (S5E Fig and S3 Table).
Selection and characterisation by PCR. For PCR analysis, the bacteria were grown in
7H9 media containing 50 μg/ml hygromycin for Mbv ΔMPB70 cultures, and 50 μg/ml hygro-
mycin and 25 μg/ml kanamycin for Mbv-Compl cultures. DNA for PCR analysis was collected
through crude DNA extraction. PCRs were performed with the Phusion High-Fidelity DNA
polymerase from NEB, using the Phusion GC Buffer. The primers listed below were used to
ascertain the presence of dipZ and/or mpb70 genes (S5A–S5C Fig) List of primers: dipZ-Forw:
GAATTACCACGCCAAAGACG; dipZ-Rev: TCATCCGTAGGTGAAGGAAAA; dipZ-
mpb70-intergenic-Forw: GCTCCGAAGAAATCATGTCG; mpb70-5’end-Rev: AGACAGCC
ACCGCCAGAG; mpb70-Rev: CTGCGACATTCCCTGCAC.
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Detection of secreted MPB70 by Western blot. The bacteria were grown in Sauton’s
media with antibiotics added as appropriate (described above). The supernatant of each strain
was collected and concentrated with Amicon Ultra-15 Centrifugal Filter Units. Protein con-
centrations were then determined using a Pierce BCA Protein Assay kit and the supernatants
were diluted to get a normalised whole protein load per well for gel electrophoresis of 25 μg.
After transfer of the proteins to the membrane, the membrane was probed using a mouse anti-
MPB70 IgG, and an anti-mouse HRP-conjugated (S5D and S5F Fig).
Isolation of primary human and bovine monocytes and differentiation into
macrophages
Human monocytes were obtained from leukocyte enriched blood fractions from healthy adult
donors provided by the British National Health Service (NHS) under strict anonymity. Bovine
blood was obtained from clinically healthy Holstein cows in mid-lactation phase (with a
somatic cell count below 100,000 as an indicator of healthy udders) housed at Bolton Park’s
Farm of the Royal Veterinary College (University of London). All animals were regularly tested
for freedom of TB infection (as per governmental guidelines) and were in addition free of
Bovine Viral Diarrhoea Virus (BVDV) and Infectious Bovine Rhinotracheitis (IBR), both viral
infections leading to immunosuppression. Blood was collected by jugular venepuncture into
sterile glass bottles containing 10% Acid Citrate Dextrose (ACD) as anticoagulant, as previ-
ously described [74]. Prior to monocyte isolation, bovine whole blood was aliquoted into 50
mL centrifugation tubes and centrifuged for 15 min at 1200 x g to collect the buffy coat. Both
human leucocyte enriched fraction and bovine buffy coat were then processed in the standard
way but with the difference that PBS-EDTA was used as the buffer for the isolation of human
monocytes, while PBS was used for the processing of bovine blood. Peripheral Blood Mono-
cytes Cells (PBMCs) were isolated by centrifugation onto a Ficoll gradient. PBMCs were then
washed and CD14-expressing monocytes were labelled with the anti-human CD14-antibody
conjugated with magnetic beads (Miltenyi #130-050-201) and isolated by direct magnetic
selection using the LS column (Miltenyi #130-042-401). Human and bovine CD14-positive
monocytes were finally incubated in RPMI 1640 medium (Gibco # 72400021) containing: Glu-
taMax, 25 mM Hepes, 10% Foetal bovine serum (FBS) and 10 ng/mL of recombinant human
GM-CSF or 20 ng/mL of recombinant bovine GM-CSF to allow differentiation into Mϕ for 7
days at 37˚C in an atmosphere containing 5% CO2.
Cell culture
After 7 days of differentiation, when Mϕ were ready for infection and during all the infection
process, GM-CSF was omitted from the culture medium. Once differentiated, MF were
washed once with PBS and detached from the petri dish by incubation for 20 min at 4˚C in
PBS-EDTA followed by gentle scrapping. Cells were seeded depending on the type of experi-
ment. For immunofluorescence, 1.8x105 cells/well were seeded into 24 well plates containing
untreated glass coverslips (diameter 10 mm, No:1.5). For stereology, electron microscopy,
transfer supernatant assays or RT-qPCR, cells were seeded into 6 well plates at a concentration
of 7x105 cells/well. Alternatively, untreated glass bottom (No:1.5) dishes with grids from
Matek Corporation (#P35G-1.5-14-C-GRID) containing 2x105 cells/dish were used for light
and electron microscopy.
Mycobacteria preparation and macrophage infection
Bacterial strains were cultured in a 50 mL centrifugal Falcon tube containing their respective
optimal media until the exponential phase was reached. One day before infection, bacteria
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were diluted to reach an Optical Density (OD600nm) of 0.4 and cultured for an additional 24 h.
Prior to infection, bacteria were pelleted by centrifugation at 2,900 x g for 5 min and washed
twice with PBS. Bacteria were pelleted again before adding an equivalent number of sterile 2.5-
to 3.5-mm glass beads that matched the pellet size into the Falcon tube (usually 4–5 beads).
The Falcon tubes were then vigorously shaken for 1 min to break up bacterial clumps. The bac-
teria were suspended in 7 ml of RPMI 1640 medium containing GlutaMax, 25 mM HEPES,
10% FBS (complete RPMI) and transferred to a 15 mL centrifugal Falcon tube. Bacterial sus-
pensions were then spun down at low speed (150 x g) for 3 min to allow the removal of the
remaining bacterial clumps. The supernatant, cleared of bacterial clumps, was transferred into
a clean 15 mL Falcon tube and the OD600nm was measured to determine the concentration of
the bacterial suspension, and further diluted in complete RPMI to reach a final OD600nm of 0.1
(based on growth curves it was determined that an OD 0.1 the density of bacteria in the culture
is 1 × 107 bacteria/ml). Bacteria were finally added to the MFs at an MOI of 10 for hMϕ infec-
tion or an MOI of 1 for bMϕ infection and incubated at 37˚C in an atmosphere containing 5%
CO2 for 2h (bacterial uptake). Cells were then washed twice with PBS, the medium was
replaced with fresh complete RPMI and incubated at 37˚C in an atmosphere containing 5%
CO2 until the samples were processed for analysis.
Supernatant stimulation assay
Human or bovine Mϕ were seeded into 6 well or 24 well plates and infected as described above.
The supernatants were then collected, sterilized by double filtration using 0.22 μm PVDF filters,
before being transferred onto naïve uninfected Mϕ. Supernatant-stimulated Mϕ were then incu-
bated for 24 h at 37˚C in an atmosphere containing 5% CO2. For each experiment, infected Mϕ
and supernatant-stimulated Mϕ were from the same donor. Finally, Mϕ were fixed overnight
with a solution of 4% PFA- PBS before being stained for immunofluorescence.
Extracellular vesicle (EV) purification
Two and a half million of bMϕ were seeded into T25 cm2 flasks and incubated in complete
RPMI, overnight at 37˚C in an atmosphere containing 5% CO2. The following day, cells were
infected with Mtb-RFP or Mbv-RFP at an MOI of 2. After 2 hours uptake, cells were washed 3
times with PBS to remove bacteria and residual FBS. Cells were then fed with RPMI 1640 with-
out FBS (5 mL per T25 cm2 flask) and incubated 24 hours at 37˚C in an atmosphere containing
5% CO2. After 24 h infection, the supernatant from two T25 cm
2 flasks (total volume of at least
10 mL) was collected and processed for EV purification using the Exo-spin purification Kit
from Cell guidance systems (#EX01). Briefly, the supernatants were cleared by ultracentrifuga-
tion at 16,000 x g for 30 min. Ten mL of cleared supernatants were then mixed with 5 mL of
Exo-spin buffer and incubated overnight at 4˚C. EVs were then precipitated by centrifugation
at 16,000 x g for 90 min. EVs pellets were then suspended in PBS and purified using a size
exclusion chromatography resin column.
A small fraction of EVs were fixed with 1% Glutaraldehyde and 4% PFA-PBS solution and
purity control was assessed by Electron microscopy. The rest of EV-enriched fractions were
finally diluted in complete RPMI and used to stimulate naïve bMϕ. After 24 h of stimulation
with EVs, cells were fixed with 4% PFA-PBS solution and the number of MNGCs was assessed
by confocal light microscopy.
Immunofluorescence and image acquisition
Immunofluorescence. Cells were cultured onto glass coverslips. Prior to immunolabeling,
cells were fixed overnight at 4˚C with a 4% PFA-PBS solution. Fixed cells were then incubated
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for 10 min at room temperature (RT) with a solution of PBS-NH4Cl 50 mM to quench free alde-
hyde groups, before being permeabilized for 20 min with PBS-Saponin 0.2%. Cells were then
blocked for 30 min with PBS-BSA 1%. For the immunofluorescence, both primary and second-
ary antibodies were diluted in PBS-Saponin 0.02%-BSA 0.1% (dilution buffer). LC3B and
LAMP-1 were labelled using a rabbit anti-LC3 (dilution 1/200) and a mouse anti-LAMP-1 (dilu-
tion 1/100). After 1 h incubation at RT, cells were washed three times with PBS and incubated
with the respective secondary antibodies for one additional hour. Cells were washed 3 times
prior to nuclei staining with DAPI. When required, the actin cytoskeleton was labelled using
phalloidin conjugated with Alexa-Fluor 488 (dilution 1/800 into dilution buffer; incubation 45
min at RT). For the detection of live versus dead cells, the cells were stained with Green Live/
Dead stain (500 nM for 10 min at RT) prior to PFA fixation. The coverslips were finally mounted
onto microscopy glass slides using Dako fluorescence mounting medium (Dako, #S3023).
Image acquisition. Confocal images were acquired using a confocal inverted microscope
(Zeiss LSM710) or Zeiss LSM880 both equipped with a 40X oil Lens or Plan-Apochromat 63x/
1.4 NA lens and excitation laser 405, 488, 561, 633 nm. For the quantification of multinucle-
ated cells, a field was randomly chosen, and images were acquired in tile scan mode (4x4) with
40X oil lens.
Image analysis
Image analysis was performed using free open-source FIJI software (NIH). Zeiss LSM confocal
images files (.czi) were opened using the BioFormats plug-in of FIJI.
Cell number and intracellular bacterial growth. Confocal images were first split into
separate channels: Cell nuclei DAPI (blue), RFP (red) corresponding to RFP-mycobacteria.
(a) To measure the number of cells, a threshold was applied to the DAPI images in order to
mask and calculate the number of nuclei. The presence of multinucleated cells in the field was
manually adjusted for each image. (b) The bacterial area was calculated by applying the thresh-
old function in the RFP-channel to mask the fluorescent bacteria. “Analyse Particles” function
of FIJI (size = 0.5–infinity, circularity = 0–1) was applied to calculate the area of each bacteria.
For each time point, the intracellular growth was expressed in bacteria (RFP) area per cell.
Intracellular markers association. Confocal images were first split into separate channels:
Cell nuclei DAPI (blue), RFP-mycobacteria (red) and Green channel corresponding to the
marker tested (e.g., LC3B). The cell number and bacteria area were determined as described in
(a) and (b). Mask corresponding to all the bacteria was created and each bacteria object was
extended from 2 pixels using the function “Dilate” and converted into a “region of interest”.
Finally, the green channel corresponding to the cellular marker was subjected to pixel intensity
measurement within the bacteria region of interest. Marker association was expressed in mean
intensity of green pixels for each bacteria object. For each marker, the fluorescence background
was measured from several fields and bacteria were considered positive when the mean intensity
of the marker> background + 1 STD. The percentage of association was calculated as follows:
number of positive bacteria x 100 / total number of bacteria. As the marker LAMP-1 was also
associated with spacious phagosomes in bMϕ, the same method was used to determine the
LAMP-1 positive bacterial compartments with a manual correction for spacious LAMP-1 posi-
tive phagosomes. The data were expressed as % of mycobacteria in LAMP-1 positive vacuole. All
values were analysed and plotted using Excel and GraphPad Prism.
Electron microscopy
Extracellular vesicle negative staining. Ten μl of sample was incubated at RT on a 200
mesh formvar/carbon grid. Grids were then washed 5 x 1 min in 200 mM HEPES (Sigma-
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Aldrich H0887) and transferred to 20 μl 1% Uranyl acetate, (UA) (Agar scientific AGR1260A)
and incubated for 1 min at RT. Excess 1% UA was removed and the grids were left to dry
before imaging. Images were acquired using a 120 kV Tecnai G2 Spirit BioTwin (FEI com-
pany) with an Orius CCD camera (Gatan Inc.)
Stereology. Transmission electron microscopy sample preparation for stereology: Cells
were washed in PBS and then fixed in 2.5% GA in 200 mM HEPES pH7.4 for 30 min at RT, fol-
lowed by overnight fixation at 4˚C. After several washes in 200 mM HEPES buffer, samples were
processed in a Pelco Biowave Pro (Ted Pella, USA) with the use of microwave energy and vac-
uum. Briefly, samples were fixed and stained using a reduced osmium, thiocarbohydrazide,
osmium (ROTO)/en bloc lead aspartate protocol. Samples for stereological analysis were dehy-
drated using an ethanol series of 50, 75, 90 and 100% then lifted from the tissue culture plastic
with propylene oxide, washed 4 times in dry acetone and transferred to 1.5 ml microcentrifuge
tubes. Samples were infiltrated with a dilution series of 50, 75, 100% of Ultra Bed Low Viscosity
Epoxy (EMS) resin to acetone mix and centrifuged at 600 x g between changes. Finally, samples
were cured for a minimum of 48 h at 60˚C before trimming and sectioning. Sectioning and imag-
ing: ultrathin sections (~50nm) were cut with an EM UC7 Ultramicrotome (Leica Microsystems)
using an oscillating ultrasonic 35˚ diamond Knife (DiaTOME) at a cutting speed of 0.6 mm/sec,
a frequency set by automatic mode, and a voltage of 6.0 volts. Images were acquired using a 120
kV Tecnai G2 Spirit BioTwin (FEI company) with an Orius CCD camera (Gatan Inc.)
Stereological analysis of Mtb infected cells: At least 22 different infected cells per group were
imaged at a magnification of 3,900 by systematic and random sampling. Cross points of the ste-
reological test grid over bacteria were counted with regard to the subcellular localization of bac-
teria, which was determined from images taken at a minimum magnification of x16,000. The
following criteria were employed for the assessment of subcellular membrane involvement: (a)
Single surrounding membrane; bacteria were, at least partially, tightly lined by a phospholipid
bilayer, representing the phagosomal membrane (b) cytosolic; bacteria were surrounded by ribo-
somes, representing the cytoplasm with no indication of the phagosomal membrane; (c) Multi-
ple surrounding membranes; bacteria were enveloped by double or multiple membrane
structures. Data are shown as the proportions of the total counts per sample group.
Real-time polymerase chain reaction (RT-qPCR)
hMϕ and bMϕ were seeded into 6 well plates (8 x 105 cells per well) and infected as described
earlier. Cells were washed three times with PBS before being lysed in Trizol (1 mL per well).
mRNAs were purified using Direct-zol RNA Miniprep kit from Zymo Research (#R2052), fol-
lowing the manufacturer’s recommendations and reverse transcribed to cDNA with Quanti-
Tect Reverse Transcription Kit (Qiagen). Quantitative real-time RT–PCR (qRT–PCR) was
performed using 11.25 ng cDNA per well with 0.5 μl TaqMan Gene Expression Assay probe
and 5 μl TaqMan Universal PCR Master Mix in a 10-μl reaction volume on an Applied Biosys-
tems QuantStudio 7 Flex Real-Time PCR System. Each reaction was performed in triplicate.
Data was analysed using ExpressionSuite for QuantStudio (Applied Biosystems). Fold change
was determined in relative quantification units using GAPDH for normalization of RT-qPCR.
TaqMan probes used were from Thermo Scientific: human IFN B1-FAM (Hs01077958-s1),
human GAPDH-FAM (Hs02786621-g1), bovine IFN B1-FAM (Bt03279050-g1) and bovine
GAPDH-FAM (Bt03210913-g1).
Secretome analysis of mycobacterial-infected bovine macrophages
Sample preparation. BMϕ were seeded into 6 well plates and infected with Mtb or Mbv
as described above. Uninfected cells were used as control. After 2 h of bacterial uptake, cells
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were washed three times with PBS and incubated in RPMI 1640 supplemented with glutamine
but without FBS and without Phenol Red for 22 h. The supernatants (2 mL) were then col-
lected and sterilized by double filtration using 0.22 μm PVDF filters. Supernatants were then
placed at -80˚C prior to being analysed.
Filter-aided sample preparation and trypsin digestion of protein samples. Samples
were processed using a modified version of the filter-aided sample preparation (FASP) [75].
Briefly, 800 μl of cell-free supernatant was denatured in 4 M urea in 50 mM triethylammonium
bicarbonate buffer (TEAB) and loaded onto a 0.5 mL Amicon ultra 30 kDa cut-off spin filter
(Millipore). Samples were centrifuged at 12,000 x g for 15 min. Filters were washed thrice/
twice by addition of 400 μL UB buffer (8 M urea in 50 mM TEAB) followed by centrifugation
(12,000 x g, 15 min). This process was repeated twice for a total of three UB washes. Samples
were reduced with 5 mM tris (2-carboxyethyl) phosphine at room temperature for 1 h and
subsequently alkylated with 10 mM iodoacetamide for 1 h in the dark. Filters were then
washed consecutively thrice/twice by addition of 400 μL UB buffer and twice by addition of
400 uL of TEAB followed by centrifugation (12,000 x g, 15 min). This process was repeated
twice for a total of three UB washes. Four hundred μL of TEAB 50 mM was added to each fil-
ter, and the samples were centrifuged (12,000 x g, 15 min). This was repeated twice for a total
of three TEAB washes.
Proteins were on-filter for 24 h at 37˚C using 200 ng trypsin in a humidified chamber. The
filter unit was placed in a new collection tube after digestion, and the peptides were obtained
in the flow-through by centrifugation (12,000 x g, 15 min). Peptides were eluted once more
from the filter unit by the addition of 250 μL 50mM TEAB and further centrifugation (12,000
x g, 15 min). Trypsin digestion was stopped with the addition of trifluoroacetic acid (TFA) at a
final concentration of 1%, and peptides were desalted using Macro C18 Spin Columns (Har-
vard Apparatus). Peptides were dried before storage at -20˚C.
Mass spectrometry. Peptides were dissolved in 2% acetonitrile containing 0.1% TFA, and
each sample was independently analysed on an Orbitrap Fusion Lumos Tribrid mass spec-
trometer (Thermo Fisher Scientific), connected to an UltiMate 3000 RSLCnano System
(Thermo Fisher Scientific). Peptides were injected on an Acclaim PepMap 100 C18 LC trap
column (100 μm ID × 20 mm, 3μm, 100Å) followed by separation on an EASY-Spray nanoLC
C18 column (75 ID μm × 500 mm, 2μm, 100Å) at a flow rate of 300 nL/min. Solvent A was
0.1% formic acid, 3% dimethyl sulfoxide in water, and solvent B was 0.1% formic acid, 3%
dimethyl sulfoxide, 20% water in acetonitrile. The gradient used for analysis was as follows:
solvent B was maintained at 3% for 5 min, followed by an increase from 3 to 35% B in 99 min,
35–90% B in 0.5 min, maintained at 90% B for 5 min, followed by a decrease to 3% in 5 min
and equilibration at 3% for 10 min. The Orbitrap Fusion Lumos was operated in positive ion
data-dependent mode for Orbitrap-MS and Ion trap-MS2 data acquisition. Data were
acquired using the Xcalibur software package. The precursor ion scan (full scan) was per-
formed in the Orbitrap in the range of 400–1600 m/z with a nominal resolution of 120,000 at
200 m/z. Ion filtering for Ion trap-MS2 data acquisition was performed using the quadrupole
with a transmission window of 1.6 m/z. The most intense ions above an intensity threshold of
5 x 103 were selected for high-energy collisional dissociation (HCD). An HCD normalized col-
lision energy of 30% was applied to the most intense ions, and fragment ions were analysed in
the Ion trap using Rapid scan rate. The number of Ion trap-MS2 events between full scans was
determined on-the-fly to maintain a 3 sec fixed duty cycle. Dynamic exclusion of ions within a
±10 ppm m/z window was implemented using a 35 sec exclusion duration. An electrospray
voltage of 2.0 kV and capillary temperature of 275˚C, with no sheath and auxiliary gas flow,
was used. The automatic gain control (AGC) settings were 4 × 105 ions with a maximum ion
accumulation time of 50 ms for Orbitrap-MS, and 1 × 104 ions with a maximum ion
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accumulation time of 45 ms for Ion trap-MS2 scans, respectively. Ions with<2+ or undeter-
mined charge state were excluded from MS2 selection.
Mass spectrometry data analysis. All tandem mass spectra were analysed using Max-
Quant 1.6.1.6 [76], and searched against the Bos taurus proteome database (containing 23,965
entries) downloaded from Uniprot on 01 December 2018. Peak list generation was performed
within MaxQuant and searches were performed using default parameters and the built-in
Andromeda search engine [77]. The enzyme specificity was set to consider fully tryptic pep-
tides, and two missed cleavages were allowed. Oxidation of methionine, N-terminal acetylation
and deamidation of asparagine and glutamine was allowed as variable modifications. Carbami-
domethylation of cysteine was allowed as fixed modification. A protein and peptide false dis-
covery rate (FDR) of less than 1% was employed in MaxQuant. Proteins were considered
confidently identified when they contained at least one unique tryptic peptide. Proteins that
contained similar peptides and that could not be differentiated based on tandem mass spec-
trometry analysis alone were grouped to satisfy the principles of parsimony. Reverse hits, con-
taminants and protein groups only identified by site were removed before downstream
analysis. A label-free quantification strategy was employed using the MaxLFQ algorithm [78]
within MaxQuant. Assigned LFQ values of protein groups containing�2 unique peptides
were used for statistical analysis in Perseus 1.6.2.3 [79]. Data were log2 transformed and fil-
tered to contain at least two valid LFQ values in one group for comparison. Missing values
were imputed using random numbers drawn from a normal distribution that simulates signals
from low abundance proteins. An analysis of variance (ANOVA) as performed, and p-values
were corrected for multiple hypothesis testing using the Benjamini-Hochberg FDR method. A
Tukey’s post-hoc test was performed to determine pairwise comparisons among means of the
different groups. A total of 192 differentially regulated proteins were identified using an
ANOVA and Tukey’s post-hoc test. Among those hits, 27 were differentially regulated between
H37Rv and M. bovis groups. (The reproducibility between the different biological replicates is
displayed in S5G and S5H Fig).
Cattle infection and histopathological analysis
Cattle infection. Lymph node tissue samples used in this study were collected from ani-
mals infected in the context of a prior study [40]. Time constraints on the large animal bio-
safety containment facility meant that the total experimental duration was limited to 16 weeks;
hence cattle had been infected with Mtb H37Rv for 10 weeks or Mbv AF2122/97 for 6 weeks at
the ‘Platform for experimentation on infectious diseases’ biocontainment level 3 suites of the
Institut National de la Recherche Agronomique (INRA), Tours, France, as previously
described [40,80]. Briefly, eight female Limousin x Simmenthal cattle of approximately six
months of age were divided into two groups of four. Animals were sedated with xylazine
(Rompun 2%, Bayer, France) according to the manufacturer’s instructions (0.2 mL/100 kg, IV
route) prior to the insertion of an endoscope through the nasal cavity into the trachea for deliv-
ery of the inoculum through a 1.8 mm internal diameter cannula (Veterinary Endoscopy Ser-
vices, U.K.) above the bronchial opening to the cardiac lobe and the main bifurcation between
left and right lobes. For each strain, an infective dose of 1 × 104 CFU was delivered endo-bron-
chially in 2 ml of 7H9 medium. Two ml of PBS were used to rinse any remains of the inoculum
into the trachea and then cannula and endoscope were withdrawn. The canal through which
the cannula was inserted into the endoscope was rinsed with 20 ml of PBS and the outside of
the endoscope was wiped with sterilizing wipes (Medichem International, U.K.) prior to infec-
tion of the next animal. Inoculation with the two different pathogens occurred at different
days; the endoscope was sterilised as recommended by the manufacturer between the two the
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infections. Retrospective counting of the inocula revealed infection with 1.66 × 104 CFU Mtb
H37Rv and 1.12 × 104 CFU Mbv AF2122/97.
Histopathological analysis. Animals inoculated with Mtb H37Rv or Mbv AF2122/97
were sacrificed 10 weeks or 6 weeks post-infection, respectively and subjected to post-mortem
analysis. In this study, tissues evaluated for gross pathology included the following, lymph
nodes: left and right parotid, lateral retropharyngeal, medial retropharyngeal, submandibular,
caudal, cranial mediastinal and cranial tracheobronchial and pulmonary lymph nodes. The
presence of gross pathological TB-like lesions was scored as previously described [40,81]. Tis-
sue samples were preserved in 10% phosphate-buffered formalin for 7 days before being
embedded in paraffin wax. Four-micron sections were cut and stained with haematoxylin and
eosin (H&E) or Ziehl-Neelsen staining for examination by light microscopy (at x100 magnifi-
cation) to assess the number, developmental stage and distribution of each granuloma (types
I-IV) [47,48], the number of Langhans’ cells as well as assessing the quantity and location of
acid fast bacilli for each granuloma within the tissue section.
Statistical analysis
Results were plotted as mean ± SEM or SD and statistical analyses were performed in Micro-
soft Excel 2010 (Microsoft) and GraphPad Prism 8 (GraphPad Software Inc.). 2-tailed Stu-
dent’s t-tests were used to compare 2 groups and 1-way ANOVA with Tukey’s multiple
comparisons was used to compare 3 or more groups. A p-value is considered significant
when < 0.05 and indicate as follow: �p<0.05; �� p<0.01; ��� p<0.001; ns: not significant.
Supporting information
S1 Fig. Physiological and morphological differences between GM-CSF-derived human and
bovine macrophages. (A) hMϕ were infected with Mtb-RFP or Mbv-RFP at an MOI of 10,
whereas bMϕ were infected at an MOI of 1. Intracellular bacteria were quantified based on
intracellular RFP signal and expressed in bacteria area per infected cells. Each dot represents
the average of 10 fields from 2 independent experiments (also with different donors). (B) Evo-
lution of the number of bMϕ during the course of infection (2 to 72 hours post-infection). (C)
Evolution of the number of hMϕ during the course of infection (2 to 120 hours post-infection).
(D) Left panel: Confocal images of hMϕ infected with Mtb-RFP or Mbv-RFP after 5 days of
infection. Brightfield was used to visualize the cells. Bacteria are visualized in red, cell nuclei
were stained with DAPI (blue) and nuclei from dead cells in green. Scale bar: 20 μm. Right
panel: Quantification of the level of cytotoxicity based on Green Live/Dead stain; uninfected.
Non-infected cells (NI) were used as a control, n represents the number of cells analysed. (E)
Left panel: Confocal images of hMϕ infected with Mtb-RFP or Mbv-RFP for 2 hours or 8 days.
Actin (in green) was used to visualize the cells. Cell nuclei were stained with DAPI (blue) and
bacteria-RFP are visualized in red. Scale bar: 20 μm. Right panel: quantification of intracellular
growth expressed in bacteria area (μm2) per hMϕ. Data are representative of 2 independent
experiments. (F and G) hMϕ and bMϕ after 7 days differentiation with GM-CSF. (F) Repre-
sentative electron microscopy images of uninfected hMϕ and bMϕ. Scale bar: 5 μm (G) Repre-
sentative confocal images of uninfected hMϕ or bMϕ fluorescently stained for the late
endosomal marker Lamp-1. The regions in the white squares are highlighted on the right-
hand side of the micrograph.
(TIF)
S2 Fig. Differential intracellular trafficking between Mtb and Mbv. hMϕ or bMϕ infected
with Mtb-RFP or Mbv-RFP (A, B, E and F) or Mtb-GFP or Mbv-GFP (C and D) for 24 h.
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Samples were fixed and fluorescently stained for the late endosomal marker Lamp-1 (A and
B), for the pH sensitive dye LysoTracker DN99 Red (LTR) (C and D) and for the autophagic
marker LC3B (E and F). For each fluorescent confocal image, the cell nuclei were stained with
DAPI. Positive association of bacteria with the different markers, delimited by a white square,
are magnified and displayed at the top right corner and the right-hand side of each image.
Scale bars represent 10 μm. Graphs represent the quantification of the marker association with
Mtb or Mbv ± SEM from three independent experiments. Each dot represents the mean rela-
tive fluorescent intensity of the cellular marker with a single or distinct bacteria group. The
population within each dotted red box corresponds to the percentage (± STD) of bacteria posi-
tive for the marker tested.
(TIF)
S3 Fig. Mbv induces multinucleation of bMϕ. (A) Fluorescence confocal images of bMϕ
infected with Mtb-RFP, Mbv-RFP or PFA-killed-Mbv-RFP for 24 h. Non-infected cells (NI)
were used as a control. The bacteria are visualized in red, the cells-actin cytoskeleton is in
white (phalloidin-488) and cell nuclei (DAPI) in cyan. The white square represents a region of
interest magnified below each image. Scale bar, 40 μm. (B) Quantification of the percentage of
MNGCs in bMϕ for each condition. Data are representative of two independent biological
repeats, each carried out in duplicate. (C) GM-CSF-bMϕ or -hMϕ were infected with Mbv-
RFP (red) for 24 h. PFA-fixed infected cells were stained with phalloidin-Alexa Fluor 488
(actin, green). DAPI (blue) was used to stain nuclei. Images presented above were acquired
using a confocal microscope. Images were analysed using Harmony software (PerkinElmer).
Actin stain was used to mask the cell bodies and determine the number and the area of the
cells detected. DAPI staining was used to segment and count the number of nuclei in each cell.
Cells containing 2 or more nuclei were considered. For each cell represented by a grey dot, val-
ues were plotted as nuclei number as a function of the cell’s area (μm2). Scale bar, 50 μm (D)
Electron microscopy image of Mbv-induced bovine MNGCs containing three or six distinct
nuclei (red arrows). Scale bar, 10 μm.
(TIF)
S4 Fig. Supernatant transfer assay for the determination of soluble factors involved in
MNGCs formation in bMϕ. (A) Supernatant transfer assay from bMϕ (non-infected (NI),
infected with Mtb or Mbv), or from hMϕ infected with Mtb or Mbv for 24 h, onto naïve bMϕ.
A fraction of supernatant from bMϕ-infected with Mbv was heat inactivated and used to stim-
ulate naïve bMϕ (heat Mbv). Graph represents the number of MNGCs formed in cultures of
naïve bMϕ following the addition of 400 μl of supernatant derived from cultures of bMϕ
infected with Mbv or Mtb (B) Supernatant transfer assay from non-infected hMϕ (NI), hMϕ-
infected with Mtb, Mbv, or bMϕ infected with Mtb or Mbv for 24 h, onto naïve hMϕ. A frac-
tion of supernatant from hMϕ-infected with Mbv was heat inactivated and used to stimulate
naïve hMϕ (heat Mbv). The graph represents the quantification of MNGCs for each condition
tested. (A and B) Data are representative of two independent experiments, each carried out in
duplicates.
(TIF)
S5 Fig. Construction of Mbv MPB70 mutants and secretome analysis. (A) Genetic arrange-
ment Mbv wild-type (WT) and Mbv mpb70 knock-out (Δmpb70) strains. (B) Genetic organi-
sation of dipZ-mpb70 genes and primer locations (C) Characterisation of Mbv mutants by
PCR. Deletion of mpb70 and maintenance of dipZ in Mbv Δmpb70 and complemented com-
pared to WT. dipZ is amplified in all the strains. mpb70 (244 bp) was amplified in the WT
strain but not in Δmpb70 and complemented strains. The PCR with a forward primer in dipZ
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and reverse primer in mpb70 gave the expected amplification of a 370 bp product for WT, but
was absent in Δmpb70. Its absence from the complemented Δmpb70/mpb70 (Compl) strain,
confirms that the location of the mpb70 gene, carried by the replicative plasmid pEW70c2, is
distal to the wild type chromosomal location. (D) Western immunoblot for detection of
MPB70 in the supernatant of the Mbv WT, Δmpb70 and complemented (Mbv-Compl) strains.
Each sample was analysed in duplicate. A 23 kDa band corresponding to MPB70 was detected
for the WT and complemented strain but not for Δmpb70 strain. (E) Graphical map of the
plasmid pGM221-1 used to generate the strain Mtb overexpressing MPT70 (Mtb-MPT70+).
The Mtb-H37Rv gene mpt70 is expressed under the control of hsp60 promotor. The clonality
of the Mtb-MPT70+ strain was sustained by the Kanamycin resistance cassette carried by the
plasmid pGM221-1. (F) Western immunoblot for detection of MPB70 and its homologous
MPT70 in the supernatant of the Mbv WT, Δmpb70, Mbv-Compl, Mtb WT and Mtb-MPT70
+ strains. A 23 kDa band corresponding to MPB70 was detected for Mbv WT, Mbv-Compl
and MTB-MPT70+ strains but not for Mbv Δmpb70 and Mtb WT strains. (G) Principal com-
ponent analysis of secretome samples. Distinct clusters of sample groups are observed that
indicate high reproducibility between replicates and major protein expression differences
between the samples analysed. (H) Unsupervised hierarchical clustering of secretome samples.
Distinct clusters of sample groups indicate high reproducibility of replicates and distinct pro-
tein expression differences between the samples. Two major clusters are observed with unin-
fected controls clustering separately from mycobacterial-infected samples. Protein groups with
lower abundance (e.g., lower LFQ intensity) are in purple and protein groups with higher
abundance are in orange.
(TIF)
S1 Table. Proteins secreted by bMϕ during infection with Mtb or Mbv.
(XLSX)
S2 Table. Mass spectrometric raw data of the secretome of non-infected (NI), Mtb- or
Mbv-infected bMϕ.
(XLSX)
S3 Table. Mycobacterial constructs.
(DOCX)
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